Product Code: GVR-4-68038-495-6
Traumatic Brain Injuries Assessment And Management Devices Market Growth & Trends:
The global traumatic brain injuries assessment and management devices market size is anticipated to reach USD 5.53 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing cases of car accidents and injuries caused due to sports, as well as rising patient preference for minimally invasive procedures, are driving the market growth. Falls are one of the leading causes of hospitalization in traumatic brain injuries (TBI) patients followed by motor vehicle accidents. According to the CDC, presently 3.5 million people are living with permanent TBI-related disability in the U.S.Thus, the increasing incidence of TBIs due to mounting cases of road accidents, and injuries are expected to fuel the product demand.
The COVID-19 outbreak in the year 2020 is expected to have a short-term and moderate impact on the market. Patients suffering from COVID-19 have subsequently shown neurologic symptoms that are expected to create a favorable environment for market growth in the near future. As per the research study published in the NCBI report 2020, certain patients hospitalized for coronavirus infection showed clinical & neurochemical signs of brain injury. This is expected to boost the product demand during the forecast period. The incorporation of the latest technologies and the introduction of new products by market players are also to drive the market during the forecast period. For instance, NanoDx System, launched by BioDirection Company, is a rapid Point-of-Care (POC) test that precisely confirms concussion/TBI in less than two minutes.
Traumatic Brain Injuries Assessment And Management Devices Market Report Highlights:
- The imaging devices segment dominated the market in 2022 as these devices are widely used in identifying patients with TBIs
- Based on technique, the ICP monitoring segment dominated the market in 2022 as this method is considered a gold standard for the measurement of accurate ICP in patients with severe brain injury
- The hospital end-use segment dominated the market in 2022 as brain surgeries are one of the most complicated procedures that are reliant on high-quality and advanced equipment, which are available in hospitals
- North America dominated the market in 2022 owing to the presence of well-established healthcare facilities and the availability of the latest treatment procedures
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Devices
- 1.1.2. Technique
- 1.1.3. End-Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Devices outlook
- 2.2.2. Technique outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. TBI Assessment and Management Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.2. Market restraint analysis
- 3.5. TBI Assessment and Management Devices Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Market Entry Strategies
Chapter 4. TBI Assessment and Management Devices Market: Devices Estimates & Trend Analysis
- 4.1. TBI Assessment and Management Devices Market, By Devices Key Takeaways
- 4.2. TBI Assessment and Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Imaging Devices
- 4.3.1. Imaging devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1. Magnetic Resonance Imaging (MRI) Devices
- 4.3.1.1.1. Magnetic resonance imaging (MRI) devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2. X-Ray
- 4.3.1.2.1. X-ray market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.3. Computed Tomography
- 4.3.1.3.1. Computed tomography market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.4. Others
- 4.3.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Monitoring Devices
- 4.4.1. Monitoring devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. TBI Assessment and Management Devices Market: Technique Estimates & Trend Analysis
- 5.1. TBI Assessment and Management Devices Market, By Technique Key Takeaways
- 5.2. TBI Assessment and Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Intracranial pressure monitoring
- 5.3.1. Intracranial pressure monitoring market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Partial pressure of oxygen in brain tissue (pBrO2)
- 5.4.1. Partial pressure of oxygen in brain tissue (pBrO2) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. TBI Assessment and Management Devices Market: End-Use Estimates & Trend Analysis
- 6.1. TBI Assessment and Management Devices Market, By End-Use Key Takeaways
- 6.2. TBI Assessment and Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Hospitals
- 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Diagnostic centers
- 6.4.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. TBI Assessment and Management Devices Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. TBI Assessment and Management Devices Market by Region: Key Marketplace Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. U.K.
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. Saudi Arabia
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. Integra Lifesciences
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. BioDirection, Inc.
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Nihon Kohden Corp.
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Compumedics Ltd.
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. InfraScan, Inc.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Oculogica
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Raumedic AG
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives